NCT05589597View on ClinicalTrials.gov

EO4010 in Previously Treated Metastatic Colorectal Carcinoma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2025

Conditions
Colorectal Cancer Metastatic
Interventions
DRUG

EO4010

Sequential assignment

Trial Locations (6)

25030

Hôpital Jean Minjoz, Besançon

34298

ICM Val d'Aurelle, Montpellier

75012

Saint Antoine hospital, Paris

77030

MD Anderson, Houston

08035

Hospital Universitari Vall d'Hebron, Barcelona

Unknown

Llavero-Hospital Clínico Universitario, Valencia

Sponsors

Lead Sponsor

Enterome
All Listed Sponsors
lead

Enterome

INDUSTRY